TNFRSF4 and cancer: Immunohistochemistry-based high expression of OX40 on breast epithelial cells and cancer cells in surgically resected specimens in patients with ductal carcinoma in situ and invasive ductal carcinoma of the breast were associated with the clinically aggressive disease; however, no differences were observed with high expression of OX40L [40].